When to use new Laboratory Analysis Procedure code 0202U
The new Laboratory Analysis Procedure code 0202U is used for the detection of SARS-CoV-2 (COVID-19) viral RNA in respiratory specimens using multiplexed nucleic acid amplification testing (NAAT) platforms. This code is specifically designed for the detection of the SARS-CoV-2 virus and should be used when performing NAAT testing for the virus.
NAAT testing is the preferred diagnostic method for the detection of SARS-CoV-2 viral RNA in respiratory specimens, such as nasopharyngeal swabs, oropharyngeal swabs, and nasal swabs. The use of code 0202U is appropriate when testing individuals who are suspected to have COVID-19 or have been exposed to individuals with COVID-19.
It is important to note that the use of specific laboratory codes, such as 0202U, is determined by the healthcare provider and the laboratory performing the test. The appropriate code to use may depend on a variety of factors, such as the type of test performed, the methodology used, and the payer requirements. It is important to consult with the appropriate billing and coding resources to determine the appropriate code to use for laboratory testing procedures.